skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:064546/0702   Pages: 11
Recorded: 08/10/2023
Attorney Dkt #:122787.00181,.182, .183
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 1
1
Patent #:
Issue Dt:
06/25/2024
Application #:
17885213
Filing Dt:
08/10/2022
Publication #:
Pub Dt:
03/23/2023
Title:
CRYSTALLINE FORMS OF N-[4-[4-(4-MORPHOLINYL)-7H-PYRROLO[2,3-d]PYRIMIDIN-6-YL]PHENYL]-4-[[3(R)-[(1-OXO-2-PROPEN-1-YL)AMINO]-1-PIPERIDINYL]METHYL]-2-PYRIDINECARBOXAMIDE AS AN IRREVERSIBLE INHIBITOR OF MENIN-MLL INTERACTION
Assignors
1
Exec Dt:
09/21/2021
2
Exec Dt:
12/09/2021
3
Exec Dt:
12/09/2021
4
Exec Dt:
12/09/2021
5
Exec Dt:
09/21/2021
6
Exec Dt:
09/21/2021
7
Exec Dt:
09/21/2021
8
Exec Dt:
09/21/2021
9
Exec Dt:
09/22/2022
Assignee
1
900 MIDDLEFIELD ROAD
REDWOOD CITY, CALIFORNIA 94063
Correspondence name and address
SQUIRE PATTON BOGGS LLP
475 SANSOME STREET, SUITE 1600
SAN FRANCISCO, CA 94111

Search Results as of: 06/22/2025 12:38 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT